Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
High-Throughput Nucleotide Sequencing | 21 | 2024 | 3665 | 1.480 |
Why?
|
Mutation | 55 | 2024 | 30243 | 1.050 |
Why?
|
Genomics | 14 | 2024 | 5909 | 0.720 |
Why?
|
Neoplasms | 20 | 2024 | 22386 | 0.720 |
Why?
|
Genome, Human | 12 | 2020 | 4453 | 0.700 |
Why?
|
Tumor Virus Infections | 2 | 2020 | 439 | 0.700 |
Why?
|
Phosphatidylinositol 3-Kinases | 11 | 2018 | 2884 | 0.670 |
Why?
|
Proto-Oncogene Proteins B-raf | 11 | 2014 | 2072 | 0.650 |
Why?
|
DNA Mutational Analysis | 21 | 2021 | 4120 | 0.560 |
Why?
|
Computational Biology | 6 | 2020 | 3546 | 0.520 |
Why?
|
Sequence Analysis, DNA | 12 | 2019 | 4780 | 0.520 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2021 | 1614 | 0.500 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 12 | 2019 | 906 | 0.500 |
Why?
|
Genotype | 12 | 2020 | 13047 | 0.470 |
Why?
|
Carcinoma | 4 | 2019 | 2341 | 0.460 |
Why?
|
DNA Copy Number Variations | 11 | 2019 | 2046 | 0.440 |
Why?
|
Adenocarcinoma | 8 | 2018 | 6400 | 0.430 |
Why?
|
Bifidobacterium | 2 | 2003 | 99 | 0.420 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2018 | 493 | 0.410 |
Why?
|
Endometrial Neoplasms | 2 | 2020 | 1382 | 0.410 |
Why?
|
Nucleic Acids | 1 | 2014 | 190 | 0.390 |
Why?
|
Gene Expression Profiling | 13 | 2021 | 9507 | 0.390 |
Why?
|
Genome, Viral | 2 | 2020 | 673 | 0.360 |
Why?
|
Polyomavirus | 2 | 2020 | 236 | 0.320 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2022 | 5426 | 0.320 |
Why?
|
Lung Neoplasms | 7 | 2022 | 13589 | 0.310 |
Why?
|
Arenavirus | 1 | 2008 | 8 | 0.310 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 5 | 2018 | 1766 | 0.300 |
Why?
|
PTEN Phosphohydrolase | 3 | 2020 | 1119 | 0.290 |
Why?
|
Histiocytosis, Langerhans-Cell | 3 | 2015 | 171 | 0.280 |
Why?
|
Genetic Predisposition to Disease | 12 | 2022 | 18048 | 0.280 |
Why?
|
DNA-Binding Proteins | 7 | 2019 | 9623 | 0.270 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2022 | 4083 | 0.270 |
Why?
|
Chromosome Aberrations | 1 | 2013 | 1781 | 0.270 |
Why?
|
Oncogenes | 8 | 2017 | 1235 | 0.270 |
Why?
|
Papillomavirus Infections | 1 | 2018 | 1638 | 0.270 |
Why?
|
MAP Kinase Kinase 1 | 3 | 2015 | 333 | 0.260 |
Why?
|
Tumor Suppressor Protein p53 | 7 | 2018 | 2964 | 0.260 |
Why?
|
Gene Dosage | 6 | 2018 | 1221 | 0.260 |
Why?
|
DNA Mismatch Repair | 2 | 2019 | 433 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2024 | 8635 | 0.250 |
Why?
|
Tumor Suppressor Proteins | 5 | 2012 | 2819 | 0.250 |
Why?
|
Subtraction Technique | 1 | 2008 | 519 | 0.240 |
Why?
|
Medical Oncology | 2 | 2023 | 2347 | 0.240 |
Why?
|
Genetic Testing | 3 | 2022 | 3586 | 0.240 |
Why?
|
Nuclear Proteins | 9 | 2022 | 5808 | 0.240 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2019 | 388 | 0.230 |
Why?
|
Micrococcal Nuclease | 1 | 2003 | 36 | 0.230 |
Why?
|
DNA Helicases | 4 | 2022 | 853 | 0.230 |
Why?
|
Uterine Neoplasms | 3 | 2018 | 1422 | 0.230 |
Why?
|
Ovarian Neoplasms | 6 | 2018 | 4906 | 0.230 |
Why?
|
Colorectal Neoplasms | 4 | 2021 | 6978 | 0.220 |
Why?
|
Genes, Tumor Suppressor | 4 | 2018 | 1064 | 0.220 |
Why?
|
Rhabdoid Tumor | 2 | 2018 | 210 | 0.220 |
Why?
|
Transcription Factors | 9 | 2022 | 12174 | 0.220 |
Why?
|
Polyomavirus Infections | 2 | 2020 | 193 | 0.210 |
Why?
|
GTP-Binding Protein alpha Subunits | 2 | 2014 | 103 | 0.210 |
Why?
|
Humans | 96 | 2024 | 768451 | 0.210 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 2 | 2016 | 196 | 0.210 |
Why?
|
Proto-Oncogene Proteins | 4 | 2014 | 4534 | 0.210 |
Why?
|
Serine | 1 | 2006 | 831 | 0.210 |
Why?
|
Genetic Complementation Test | 1 | 2003 | 557 | 0.200 |
Why?
|
Osteosarcoma | 2 | 2023 | 912 | 0.200 |
Why?
|
Skin Neoplasms | 6 | 2021 | 5891 | 0.200 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2006 | 697 | 0.200 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2023 | 219 | 0.180 |
Why?
|
Nevus | 1 | 2023 | 206 | 0.180 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2020 | 331 | 0.180 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3611 | 0.180 |
Why?
|
Gene Amplification | 4 | 2023 | 1091 | 0.180 |
Why?
|
Indoles | 4 | 2014 | 1834 | 0.180 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2021 | 1644 | 0.170 |
Why?
|
Polymerase Chain Reaction | 3 | 2017 | 6091 | 0.170 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2019 | 323 | 0.170 |
Why?
|
Bacterial Proteins | 2 | 2003 | 3861 | 0.170 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3794 | 0.170 |
Why?
|
Brain Neoplasms | 6 | 2024 | 9182 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2020 | 16029 | 0.160 |
Why?
|
ras Proteins | 3 | 2014 | 1058 | 0.160 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 46 | 0.160 |
Why?
|
Sulfonamides | 4 | 2014 | 1988 | 0.160 |
Why?
|
Mullerian Ducts | 2 | 2018 | 203 | 0.160 |
Why?
|
Breast Neoplasms, Male | 1 | 2020 | 212 | 0.160 |
Why?
|
Papillomaviridae | 3 | 2024 | 1135 | 0.160 |
Why?
|
Adnexal Diseases | 1 | 2019 | 105 | 0.160 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2021 | 238 | 0.160 |
Why?
|
Melanoma | 5 | 2023 | 5740 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2019 | 190 | 0.160 |
Why?
|
Cell Transformation, Viral | 1 | 2020 | 530 | 0.150 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2018 | 102 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 5 | 2021 | 5709 | 0.150 |
Why?
|
Pituitary Neoplasms | 2 | 2017 | 1325 | 0.150 |
Why?
|
Sensitivity and Specificity | 4 | 2020 | 14728 | 0.150 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2015 | 2040 | 0.150 |
Why?
|
Carcinoma in Situ | 2 | 2016 | 791 | 0.150 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2014 | 733 | 0.150 |
Why?
|
Virus Integration | 1 | 2020 | 306 | 0.150 |
Why?
|
Adenoma | 2 | 2019 | 2163 | 0.150 |
Why?
|
Aged | 32 | 2024 | 171520 | 0.150 |
Why?
|
Aged, 80 and over | 19 | 2021 | 59680 | 0.140 |
Why?
|
Tennessee | 1 | 2017 | 123 | 0.140 |
Why?
|
Female | 48 | 2024 | 396943 | 0.140 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2021 | 1628 | 0.140 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 595 | 0.140 |
Why?
|
BRCA2 Protein | 1 | 2022 | 802 | 0.140 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2003 | 1139 | 0.140 |
Why?
|
Chromosomes, Human | 2 | 2016 | 444 | 0.140 |
Why?
|
Signal Transduction | 9 | 2018 | 23638 | 0.140 |
Why?
|
Genes, ras | 4 | 2016 | 666 | 0.140 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2020 | 342 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9425 | 0.130 |
Why?
|
Head and Neck Neoplasms | 3 | 2024 | 2915 | 0.130 |
Why?
|
Mesonephroma | 1 | 2015 | 21 | 0.130 |
Why?
|
Bone Neoplasms | 2 | 2023 | 2562 | 0.130 |
Why?
|
Information Dissemination | 1 | 2024 | 1138 | 0.130 |
Why?
|
Frameshift Mutation | 2 | 2018 | 393 | 0.130 |
Why?
|
Stomach Neoplasms | 2 | 2019 | 1484 | 0.130 |
Why?
|
BRCA1 Protein | 1 | 2022 | 1158 | 0.130 |
Why?
|
Carcinoma, Basal Cell | 1 | 2021 | 564 | 0.130 |
Why?
|
Middle Aged | 34 | 2024 | 223418 | 0.120 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2015 | 56 | 0.120 |
Why?
|
Ovarian Cysts | 1 | 2016 | 108 | 0.120 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 3735 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 959 | 0.120 |
Why?
|
Port-Wine Stain | 1 | 2014 | 33 | 0.120 |
Why?
|
Adult | 33 | 2024 | 223542 | 0.120 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2018 | 5342 | 0.120 |
Why?
|
Prognosis | 10 | 2023 | 30028 | 0.120 |
Why?
|
Adenosarcoma | 1 | 2014 | 36 | 0.120 |
Why?
|
Craniopharyngioma | 1 | 2017 | 279 | 0.120 |
Why?
|
Proto-Oncogene Proteins A-raf | 1 | 2014 | 9 | 0.120 |
Why?
|
Gene Fusion | 1 | 2017 | 356 | 0.120 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 539 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2014 | 712 | 0.110 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 71 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 3 | 2012 | 639 | 0.110 |
Why?
|
Facial Dermatoses | 1 | 2014 | 87 | 0.110 |
Why?
|
Sequence Analysis | 1 | 2014 | 240 | 0.110 |
Why?
|
Neuroblastoma | 1 | 2022 | 1265 | 0.110 |
Why?
|
Vulvar Neoplasms | 1 | 2016 | 267 | 0.110 |
Why?
|
Survival Analysis | 4 | 2020 | 10125 | 0.110 |
Why?
|
Comparative Genomic Hybridization | 4 | 2017 | 474 | 0.110 |
Why?
|
Rhabdomyoma | 1 | 2013 | 56 | 0.110 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2016 | 329 | 0.110 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 640 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2021 | 2525 | 0.110 |
Why?
|
Male | 34 | 2024 | 364781 | 0.110 |
Why?
|
Antineoplastic Agents | 4 | 2015 | 13708 | 0.110 |
Why?
|
Genes, Neoplasm | 1 | 2014 | 370 | 0.100 |
Why?
|
Encyclopedias as Topic | 1 | 2012 | 19 | 0.100 |
Why?
|
Muscle Neoplasms | 1 | 2013 | 130 | 0.100 |
Why?
|
Chromosome Deletion | 2 | 2014 | 1390 | 0.100 |
Why?
|
Germ-Line Mutation | 3 | 2022 | 1884 | 0.100 |
Why?
|
Phylogeny | 1 | 2020 | 2846 | 0.100 |
Why?
|
Glioma | 3 | 2013 | 3523 | 0.100 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2012 | 453 | 0.100 |
Why?
|
Breast Neoplasms | 5 | 2023 | 21156 | 0.100 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2016 | 526 | 0.100 |
Why?
|
Pericytes | 1 | 2014 | 299 | 0.100 |
Why?
|
Colonic Neoplasms | 2 | 2016 | 2544 | 0.100 |
Why?
|
Ovary | 1 | 2016 | 960 | 0.090 |
Why?
|
Sarcoma | 1 | 2022 | 1806 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20231 | 0.090 |
Why?
|
Cadherins | 1 | 2016 | 906 | 0.090 |
Why?
|
Chordoma | 1 | 2014 | 350 | 0.090 |
Why?
|
Genes, myc | 1 | 2012 | 391 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 4586 | 0.090 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 506 | 0.090 |
Why?
|
Diffusion of Innovation | 1 | 2015 | 730 | 0.090 |
Why?
|
Pons | 1 | 2011 | 242 | 0.090 |
Why?
|
raf Kinases | 1 | 2011 | 118 | 0.090 |
Why?
|
Prostatectomy | 1 | 2018 | 1840 | 0.090 |
Why?
|
Biopsy | 4 | 2018 | 6816 | 0.090 |
Why?
|
Genome | 2 | 2009 | 1749 | 0.090 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2014 | 480 | 0.090 |
Why?
|
Angiomyolipoma | 1 | 2011 | 188 | 0.090 |
Why?
|
Inheritance Patterns | 1 | 2012 | 341 | 0.080 |
Why?
|
Brain Stem Neoplasms | 1 | 2011 | 191 | 0.080 |
Why?
|
Peritoneal Neoplasms | 1 | 2016 | 715 | 0.080 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2010 | 95 | 0.080 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2012 | 720 | 0.080 |
Why?
|
Uveal Neoplasms | 1 | 2012 | 344 | 0.080 |
Why?
|
Databases, Genetic | 3 | 2016 | 1750 | 0.080 |
Why?
|
Gallbladder Neoplasms | 1 | 2011 | 191 | 0.080 |
Why?
|
Loss of Heterozygosity | 1 | 2011 | 663 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1905 | 0.080 |
Why?
|
Wolffian Ducts | 2 | 2019 | 27 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2011 | 3463 | 0.080 |
Why?
|
DNA Primers | 2 | 2011 | 2826 | 0.080 |
Why?
|
Hedgehog Proteins | 1 | 2013 | 770 | 0.080 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2011 | 212 | 0.080 |
Why?
|
Cohort Studies | 8 | 2021 | 41797 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 2003 | 0.080 |
Why?
|
Neoplasm Staging | 7 | 2020 | 11249 | 0.080 |
Why?
|
Lymphoproliferative Disorders | 1 | 2012 | 531 | 0.080 |
Why?
|
Codon | 1 | 2009 | 599 | 0.070 |
Why?
|
Cell Line, Tumor | 10 | 2014 | 17149 | 0.070 |
Why?
|
Genetic Variation | 2 | 2017 | 6610 | 0.070 |
Why?
|
Gene Deletion | 2 | 2013 | 2674 | 0.070 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2011 | 489 | 0.070 |
Why?
|
Databases, Nucleic Acid | 1 | 2008 | 204 | 0.070 |
Why?
|
Protein Methyltransferases | 1 | 2006 | 54 | 0.070 |
Why?
|
Astrocytoma | 1 | 2011 | 780 | 0.070 |
Why?
|
Molecular Targeted Therapy | 3 | 2024 | 2834 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2013 | 2465 | 0.070 |
Why?
|
DNA, Neoplasm | 3 | 2020 | 1749 | 0.070 |
Why?
|
Telomere | 1 | 2012 | 943 | 0.060 |
Why?
|
Tumor Burden | 2 | 2022 | 1909 | 0.060 |
Why?
|
HL-60 Cells | 1 | 2006 | 364 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2014 | 3619 | 0.060 |
Why?
|
Mutation, Missense | 2 | 2012 | 2594 | 0.060 |
Why?
|
Genetic Markers | 1 | 2012 | 2604 | 0.060 |
Why?
|
Phenotype | 4 | 2018 | 16712 | 0.060 |
Why?
|
Mass Spectrometry | 4 | 2014 | 2204 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1254 | 0.060 |
Why?
|
Young Adult | 9 | 2022 | 60045 | 0.060 |
Why?
|
High-Throughput Screening Assays | 1 | 2011 | 940 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2010 | 998 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3230 | 0.060 |
Why?
|
Genetic Techniques | 1 | 2007 | 428 | 0.060 |
Why?
|
Embryonic Development | 1 | 2009 | 722 | 0.060 |
Why?
|
Clinical Trials as Topic | 3 | 2024 | 8051 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2022 | 11138 | 0.060 |
Why?
|
Benzimidazoles | 1 | 2009 | 864 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2062 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9361 | 0.060 |
Why?
|
Child, Preschool | 8 | 2024 | 42623 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2013 | 2819 | 0.060 |
Why?
|
DNA Damage | 3 | 2012 | 2461 | 0.060 |
Why?
|
beta Catenin | 2 | 2023 | 1048 | 0.060 |
Why?
|
Meningioma | 1 | 2013 | 1222 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4728 | 0.060 |
Why?
|
Alleles | 3 | 2013 | 6890 | 0.060 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2006 | 856 | 0.060 |
Why?
|
Cell Movement | 1 | 2016 | 5223 | 0.060 |
Why?
|
Phosphorylation | 3 | 2015 | 8332 | 0.050 |
Why?
|
Trans-Activators | 1 | 2013 | 2858 | 0.050 |
Why?
|
Paraffin Embedding | 2 | 2017 | 306 | 0.050 |
Why?
|
Patient Selection | 1 | 2015 | 4266 | 0.050 |
Why?
|
Molecular Sequence Data | 3 | 2009 | 17647 | 0.050 |
Why?
|
Social Class | 1 | 2012 | 2000 | 0.050 |
Why?
|
Zebrafish Proteins | 1 | 2009 | 1019 | 0.050 |
Why?
|
Protein Sorting Signals | 1 | 2003 | 275 | 0.050 |
Why?
|
Formaldehyde | 2 | 2017 | 361 | 0.050 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2014 | 148 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15460 | 0.050 |
Why?
|
Smoking | 2 | 2017 | 9099 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2020 | 6537 | 0.050 |
Why?
|
Child | 10 | 2024 | 80863 | 0.050 |
Why?
|
Amino Acid Substitution | 3 | 2012 | 1744 | 0.050 |
Why?
|
Prospective Studies | 5 | 2022 | 54914 | 0.050 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2023 | 182 | 0.050 |
Why?
|
Prostatic Neoplasms | 2 | 2018 | 11206 | 0.050 |
Why?
|
Infant | 6 | 2024 | 36497 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2012 | 1676 | 0.050 |
Why?
|
Histones | 1 | 2012 | 2595 | 0.050 |
Why?
|
Protein Conformation | 1 | 2009 | 3973 | 0.050 |
Why?
|
Protein Isoforms | 1 | 2006 | 1706 | 0.050 |
Why?
|
GTP Phosphohydrolases | 2 | 2015 | 525 | 0.050 |
Why?
|
Algorithms | 2 | 2014 | 14158 | 0.050 |
Why?
|
NF-kappa B | 1 | 2010 | 2491 | 0.050 |
Why?
|
Base Sequence | 3 | 2013 | 12428 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2014 | 2360 | 0.050 |
Why?
|
Adolescent | 8 | 2024 | 89168 | 0.040 |
Why?
|
Prevalence | 1 | 2017 | 15880 | 0.040 |
Why?
|
Exons | 2 | 2019 | 2392 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6856 | 0.040 |
Why?
|
Neoplasm Invasiveness | 3 | 2014 | 3637 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2007 | 4622 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2016 | 2477 | 0.040 |
Why?
|
Research Design | 2 | 2012 | 6217 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12875 | 0.040 |
Why?
|
Transfection | 1 | 2006 | 5767 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2014 | 2910 | 0.040 |
Why?
|
Protein Binding | 2 | 2009 | 9376 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2014 | 12774 | 0.040 |
Why?
|
Protein Transport | 1 | 2003 | 1963 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 614 | 0.040 |
Why?
|
Zebrafish | 1 | 2009 | 3038 | 0.040 |
Why?
|
Germ Cells | 1 | 2021 | 641 | 0.040 |
Why?
|
Models, Genetic | 1 | 2007 | 3442 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2006 | 2430 | 0.030 |
Why?
|
Introns | 1 | 2019 | 970 | 0.030 |
Why?
|
Chromogranins | 1 | 2017 | 160 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 3826 | 0.030 |
Why?
|
Pedigree | 2 | 2016 | 4545 | 0.030 |
Why?
|
Databases, Factual | 1 | 2012 | 8081 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2012 | 3412 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2024 | 26395 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2021 | 1139 | 0.030 |
Why?
|
Cell Lineage | 2 | 2018 | 2575 | 0.030 |
Why?
|
Models, Biological | 1 | 2012 | 9505 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 267 | 0.030 |
Why?
|
Microsatellite Instability | 1 | 2019 | 726 | 0.030 |
Why?
|
Receptor, EphA3 | 1 | 2014 | 13 | 0.030 |
Why?
|
Genes, myb | 1 | 2014 | 18 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2018 | 11674 | 0.030 |
Why?
|
MAP Kinase Signaling System | 2 | 2014 | 1489 | 0.030 |
Why?
|
Hong Kong | 1 | 2015 | 168 | 0.030 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2018 | 326 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4298 | 0.030 |
Why?
|
BALB 3T3 Cells | 1 | 2014 | 10 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2022 | 2216 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2021 | 81834 | 0.030 |
Why?
|
Uterus | 1 | 2018 | 660 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1282 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 183 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2016 | 962 | 0.030 |
Why?
|
Genetic Association Studies | 2 | 2014 | 2742 | 0.030 |
Why?
|
Langerhans Cells | 1 | 2014 | 169 | 0.030 |
Why?
|
Software | 1 | 2007 | 4463 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2206 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2023 | 2586 | 0.030 |
Why?
|
Genes, erbB-1 | 1 | 2013 | 163 | 0.030 |
Why?
|
Valine | 1 | 2014 | 410 | 0.030 |
Why?
|
Topoisomerase Inhibitors | 1 | 2012 | 19 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 387 | 0.030 |
Why?
|
Animals | 7 | 2014 | 169418 | 0.030 |
Why?
|
Chromosome Duplication | 1 | 2012 | 76 | 0.020 |
Why?
|
Disease Progression | 3 | 2016 | 13655 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2003 | 13452 | 0.020 |
Why?
|
Apoptosis | 3 | 2016 | 9526 | 0.020 |
Why?
|
Co-Repressor Proteins | 1 | 2012 | 190 | 0.020 |
Why?
|
Neurofibromin 2 | 1 | 2013 | 272 | 0.020 |
Why?
|
Phosphatidylethanolamine Binding Protein | 1 | 2011 | 8 | 0.020 |
Why?
|
3T3 Cells | 1 | 2013 | 1086 | 0.020 |
Why?
|
Cell Cycle | 2 | 2010 | 2942 | 0.020 |
Why?
|
Social Identification | 1 | 2012 | 108 | 0.020 |
Why?
|
Benzenesulfonates | 1 | 2011 | 166 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1688 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2006 | 19041 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2011 | 162 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2018 | 1539 | 0.020 |
Why?
|
Neoplasm Metastasis | 2 | 2012 | 4931 | 0.020 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2011 | 199 | 0.020 |
Why?
|
Sezary Syndrome | 1 | 2011 | 80 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2021 | 2987 | 0.020 |
Why?
|
Tumor Stem Cell Assay | 1 | 2009 | 116 | 0.020 |
Why?
|
Multigene Family | 1 | 2013 | 1081 | 0.020 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2012 | 222 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2014 | 1145 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 2016 | 988 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2012 | 384 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 819 | 0.020 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2011 | 304 | 0.020 |
Why?
|
Niacinamide | 1 | 2011 | 419 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2016 | 10494 | 0.020 |
Why?
|
Mycosis Fungoides | 1 | 2011 | 170 | 0.020 |
Why?
|
Genes, jun | 1 | 2008 | 69 | 0.020 |
Why?
|
Emigration and Immigration | 1 | 2012 | 405 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2016 | 12813 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39430 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2640 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2014 | 1192 | 0.020 |
Why?
|
Plasma Cells | 1 | 2012 | 598 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2863 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1706 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2011 | 532 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1669 | 0.020 |
Why?
|
Mice | 5 | 2014 | 82045 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6135 | 0.020 |
Why?
|
Culture | 1 | 2012 | 624 | 0.020 |
Why?
|
SEER Program | 1 | 2013 | 1476 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2014 | 3594 | 0.020 |
Why?
|
Genomic Instability | 1 | 2012 | 714 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 677 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2015 | 7895 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 633 | 0.020 |
Why?
|
Prejudice | 1 | 2012 | 574 | 0.020 |
Why?
|
Molecular Chaperones | 1 | 2012 | 764 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 617 | 0.020 |
Why?
|
Antigens, CD1 | 1 | 2010 | 434 | 0.020 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2012 | 614 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2731 | 0.020 |
Why?
|
Cell Size | 1 | 2009 | 626 | 0.020 |
Why?
|
Telomerase | 1 | 2012 | 751 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1755 | 0.020 |
Why?
|
Mice, Nude | 1 | 2013 | 3635 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2896 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3615 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2011 | 1840 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3790 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3090 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2017 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2009 | 910 | 0.020 |
Why?
|
Neuropeptides | 1 | 2011 | 950 | 0.020 |
Why?
|
Mutagenesis | 1 | 2009 | 1230 | 0.020 |
Why?
|
Cholangiocarcinoma | 1 | 2011 | 563 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1972 | 0.020 |
Why?
|
Bile Duct Neoplasms | 1 | 2011 | 617 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4294 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2847 | 0.010 |
Why?
|
Estrogen Receptor alpha | 1 | 2008 | 582 | 0.010 |
Why?
|
Myeloid Cells | 1 | 2009 | 833 | 0.010 |
Why?
|
Health Services Research | 1 | 2012 | 1815 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 13026 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13324 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2010 | 1751 | 0.010 |
Why?
|
DNA Repair | 1 | 2012 | 2051 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12096 | 0.010 |
Why?
|
Risk Factors | 3 | 2016 | 74915 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12561 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8908 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9558 | 0.010 |
Why?
|
Genetic Loci | 1 | 2010 | 2630 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7605 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5801 | 0.010 |
Why?
|
Pyrimidines | 1 | 2012 | 3050 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2009 | 2058 | 0.010 |
Why?
|
Pyridines | 1 | 2011 | 2888 | 0.010 |
Why?
|
Proteome | 1 | 2008 | 1881 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7863 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10647 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3543 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4362 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18388 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 65409 | 0.010 |
Why?
|